tert-Butyl 3-fluoro-4-hydroxypiperidine-1-carboxylate, 95.0%, 10g

2,3,3-Trimethyl-3H-indol-5-amine, 95.0%, 10g

4,8-Bis(n-octyloxy)benzo[1,2-b:4,5-b']dithiophene-2,6-dicarbaldehyde>97.0%(GC)200mg

1,2-bis(4-Bromophenyl)ethane, 97%, 5g

5-Chloromethyl-2-(4-(trifluoromethyl)phenyl)-1H-imidazole, 95.0%, 1g

N-Boc-1,2,3,4-Tetrahydroisoquinoline-6-carboxylic acid, 97.0%, 1g

N-(5-Bromo-4-ethylthiazol-2-yl)acetamide, 95.0%, 1g

Bis-(sodium sulfopropyl)-disulfide, 99.0%, 25g

GC capillary column ROTI®Cap-1, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

1-Benzyl 3-methyl 5-hydroxypiperidine-1,3-dicarboxylate, 95.0%, 250mg

tert-Butyl 6-nitro-1H-indazole-1-carboxylate, 95.0%, 10g

3-Bromo-2-fluoro-6-iodobenzonitrile, 90.0%, 25g

2,4-Difluoropyridine, 98.0%, 25g